Shin Hong Jang

Title: Innovations of Shin Hong Jang in Pharmaceutical Formulations.

Introduction

Shin Hong Jang is a notable inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of stable liquid medications. His work is characterized by a focus on improving the stability and efficacy of pharmaceutical compounds.

Latest Patents

One of Shin Hong Jang's key inventions is a stable pharmaceutical formulation of cabazitaxel. This patent describes a stable liquid cabazitaxel formulation contained within an enclosed container. The formulation includes a liquid phase comprising cabazitaxel, polysorbate 80, ethanol, and one or more pH adjusters to maintain a pH of about 2.8-6.0. Additionally, the gaseous phase within the container is saturated with carbon dioxide. This innovative approach enhances the stability of the pharmaceutical composition, making it more effective for medical use.

Career Highlights

Shin Hong Jang is associated with Yung Shin Pharm. Ind. Co., Ltd., where he has been instrumental in developing new pharmaceutical formulations. His expertise in the field has led to advancements that benefit both the industry and patients requiring effective treatments.

Collaborations

Shin collaborates with talented colleagues, including Chiung Ju Tsai and Tsang-Miao Huang. Their combined efforts contribute to the innovative environment at Yung Shin Pharm. Ind. Co., Ltd., fostering the development of groundbreaking pharmaceutical solutions.

Conclusion

Shin Hong Jang's contributions to pharmaceutical formulations, particularly his stable cabazitaxel formulation, highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in medication stability and efficacy.